Total medical devices industry cross border venture financing deals worth $586m were announced in North America in March 2022, led by $125m venture financing of BillionToOne, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked a decrease of 15.8% over the previous month of $695.89m and a drop of 7.2% when compared with the last 12-month average of $631.32m.
North America held an 82.30% share of the global medical devices industry cross border venture financing deal value that totalled $712.04m in March 2022. With a 79.14% share and deals worth $563.5m, the US was the top country in North America’s cross border venture financing deal value across medical devices industry.
In terms of cross border venture financing deal activity, North America recorded 24 deals during March 2022, marking an increase of 50.00% over the previous month and a rise of 60.00% over the 12-month average. The US recorded 21 deals during the month.
North America medical devices industry cross border venture financing deals in March 2022: Top deals
The top five medical devices industry cross border venture financing deals accounted for 70.6% of the overall value during March 2022.
The combined value of the top five medical devices cross border venture financing deals stood at $413.4m, against the overall value of $586m recorded for the month.
The top five medical devices industry cross border venture financing deals of March 2022 tracked by GlobalData were:
1) Adams Street Partners,Baillie Gifford,Civilization Ventures,Fifty Years Fund,Hummingbird Ventures,Libertus Capital,NeoTribe Ventures,Norwest Venture Partners,Pacific 8 Ventures and Time BioVentures $125m venture financing deal with BillionToOne
2) The $100m venture financing of Visby Medical by Artiman Ventures,Blue Water Life Science Advisors,Cedars-Sinai Medical Center,Healthcare of Ontario Pension Plan,John Doerr,ND Capital,Nissim Capital,Ping An Voyager Partners and Pitango Venture Capital
3) Ally Bridge Group,Ascension Health Ventures,Catalio Capital Management,Hillenbrand Capital,Johnson & Johnson Innovation – JJDC,KCK Group,Pfizer Venture Investments,PSP INVESTMENTS,Sixty Degree Capital,T Rowe Price Associates,The Rise Fund and Venrock Healthcare Capital Partners $80m venture financing deal with RefleXion Medical
4) The $73m venture financing of Deepcell by Andreessen Horowitz,Bow Capital,Bridger Healthcare Partners,Casdin Capital,Horizons Ventures,Jeff Dean,Koch Disruptive Technologies and Matthew McIlwain
5) MicroPort CardioFlow Medtech $35.4m venture financing deal with 4C Medical Technologies
Verdict deals analysis methodology
This analysis considers only announced and completed cross border deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.
GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.
More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.